Molecular imaging implies the method capable of pictorially displaying distribution of target molecules and their relative concentration in space. In clinical medicine, where non-invasiveness is mandatory, diagnostic molecular imaging has been considered virtually identical to positron emission tomography (PET). However, there is another powerful, apparently underutilized molecular imaging, namely, proton magnetic resonance spectroscopic imaging ( 1 H-MRSI 
Introduction
Recent advances in molecular imaging, which implies the method capable of pictorially displaying distribution of target molecules and their relative concentration in space, provide opportunity to assess the physical and pathological basis of live tissue. In clinical field, PET plays a main role for most of the field of molecular imaging. However, elimination of all invasive aspects from diagnostic imaging, including intravenous infusion or use of ionizing radiation, is one of the final goals for the clinical imaging.
Proton magnetic resonance spectroscopy ( 
H-MRS
Magnetic resonance spectroscopy can non-invasively detect molecules in live tissues ( Fig. 1-a) in virtue of their own specific resonance frequencies (chemical shift). The use of a spatial encoding technique would allow each peak to map tissue distributions (e.g., 1 H-magnetic resonance spectroscopic imaging, 1 H-MRSI; Fig. 1-b) . , has become the primary focus of research. Fig. 1-a) in high-field MR systems.
Glutamate is the most abundant excitatory neurotransmitter in the mammalian brain. A unique twocompartment metabolic pathway between neurons (mainly synapse) and astrocytes, the glutamate-glutamine cycle, plays a primary role in excitatory neurotransmission 9 . As a metabolite, glucose is the primary source for de novo glutamate synthesis, and transamination between several amino acids and glutamate forms intermediate cellular metabolites 10 . Because visible glutamate in MRS represents the sum of these glutamates, changes in the glutamate peak in a pathological condition should be carefully interpreted according to the suspected mechanism. In brief, the mechanism of these changes can be interpreted as static or dynamic changes in a pathological condition. Static changes affecting the glutamate peak mainly involve chronic morphological changes such as synaptic losses in Alzheimer's disease 11 . Dynamic changes affecting the glutamate peak mainly involve acute metabolic changes due to a pathological condition. Fig. 3 Simplified schematic illustration of CEST effect and image acquisition procedure of glutamate The saturation of amine protons of glutamate, exhibiting a specific chemical shift 3 ppm downfield of water protons (a), by preparation before MRI acquisition led to the exchange of these saturated protons (which means that these protons become "inactive" as the MR signal source) with water protons (b). This procedure decreased the MRI signal intensity according to the glutamate concentration and exchange rate. Subtraction of saturated image from unsaturated image reveals distribution of CEST effect (asymmetry index versus mirror position of water frequency; c).
H-MRSI MRI
(b) MRI aquisi excha gi g pr t satura measureme t mi g Fig. 4 Multiparametric MR of a mouse model of acute focal ischemia Reduced pH of the ischemic lesion in APT MRI as well as increase in glutamate in the ischemic lesion, particularly at the border zone, were clearly shown in CEST MRI. This change in glutamate in the ischemic lesion was also visible using 1 H-MRS, which could quantify the concentration of glutamate. ADC: apparent diffusion coefficient, CASL: continuous arterial spin labeling, TTC: 2,3,5-triphenyl tetrazolium chloride, Glu: glutamate, Lac: lactate. However, some issues such as a high specific absorption rate (SAR) 17 and susceptibility to magnetic field heterogeneity 18 should be resolved before applying this technique to routine clinical settings.
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Conclusion
Recent MR techniques, particularly CEST MRI, allow the noninvasive measurement of neurotransmitter-related molecules in the brain and therefore provide new research and diagnostic strategies. MRI of neurotransmitterrelated molecules can be a potential diagnostic tool in clinical settings in the future.
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